Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial.
- DOI
- 10.1016/s1470-2045(15)00461-1
- Published
- 2015-12-17
- Container
- Lancet Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-15-00461-1,
title = {Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial.},
author = {Glover M and Smerdon GR and Andreyev HJ and Benton BE and Bothma P and Firth O and Gothard L and Harrison J and Ignatescu M and Laden G and Martin S and Maynard L and McCann D and Penny CEL and Phillips S and Sharp G and Yarnold J.},
year = {2016},
journal = {Lancet Oncol},
doi = {10.1016/s1470-2045(15)00461-1},
url = {https://doi.org/10.1016/s1470-2045(15)00461-1}
}RIS
TY - JOUR TI - Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. AU - Glover M AU - Smerdon GR AU - Andreyev HJ AU - Benton BE AU - Bothma P AU - Firth O AU - Gothard L AU - Harrison J AU - Ignatescu M AU - Laden G AU - Martin S AU - Maynard L AU - McCann D AU - Penny CEL AU - Phillips S AU - Sharp G AU - Yarnold J. PY - 2016 JO - Lancet Oncol DO - 10.1016/s1470-2045(15)00461-1 UR - https://doi.org/10.1016/s1470-2045(15)00461-1 ER -
APA
M, G., GR, S., HJ, A., BE, B., P, B., O, F., L, G., J, H., M, I., G, L., S, M., L, M., D, M., CEL, P., S, P., G, S., & J., Y. (2016). Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial.. Lancet Oncol. https://doi.org/10.1016/s1470-2045(15)00461-1
Source records
- europe-pmc · retrieved 2026-09-27T02:06:55.638Z